Progress and challenges towards targeted delivery of cancer therapeutics
Targeted delivery strategies based on nanocarriers have immense potential to change cancer care but current strategies have been shown only limited translation in the clinic. Here, the authors survey the challenge, progress and opportunities towards targeted delivery of cancer therapeutics.
Guardado en:
Autores principales: | Daniel Rosenblum, Nitin Joshi, Wei Tao, Jeffrey M. Karp, Dan Peer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25e604cc13ac4c12bb8b55a0999fbfab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
por: Nuphar Veiga, et al.
Publicado: (2018) -
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target
por: Jiao-jiao Yu, et al.
Publicado: (2020) -
Microneedles in Drug Delivery: Progress and Challenges
por: Muhammet Avcil, et al.
Publicado: (2021) -
Targeted Delivery of Therapeutic Gas by Microbubbles
por: Lingling Xu, MM, Yihan Chen, MM, Qiaofeng Jin, PhD, Li Zhang, MD, Wenpei Fu, BS, Shan Lin, MM, Ling Lin, BS, Rui Wang, BS, Dandan Chen, MM, Zhengyang Han, MM, Mingxing Xie, MD, Yali Yang, MD
Publicado: (2021) -
Towards an arthritis flare-responsive drug delivery system
por: Nitin Joshi, et al.
Publicado: (2018)